111 related articles for article (PubMed ID: 38214937)
21. Regulatory T cells expanded from HIV-1-infected individuals maintain phenotype, TCR repertoire and suppressive capacity.
Angin M; Klarenbeek PL; King M; Sharma SM; Moodley ES; Rezai A; Piechocka-Trocha A; Toth I; Chan AT; Goulder PJ; Ndung'u T; Kwon DS; Addo MM
PLoS One; 2014; 9(2):e86920. PubMed ID: 24498287
[TBL] [Abstract][Full Text] [Related]
22. Immune suppression in premalignant respiratory papillomas: enriched functional CD4+Foxp3+ regulatory T cells and PD-1/PD-L1/L2 expression.
Hatam LJ; Devoti JA; Rosenthal DW; Lam F; Abramson AL; Steinberg BM; Bonagura VR
Clin Cancer Res; 2012 Apr; 18(7):1925-35. PubMed ID: 22322668
[TBL] [Abstract][Full Text] [Related]
23. Dysfunctional CD39(POS) regulatory T cells and aberrant control of T-helper type 17 cells in autoimmune hepatitis.
Grant CR; Liberal R; Holder BS; Cardone J; Ma Y; Robson SC; Mieli-Vergani G; Vergani D; Longhi MS
Hepatology; 2014 Mar; 59(3):1007-15. PubMed ID: 23787765
[TBL] [Abstract][Full Text] [Related]
24. Comprehensive phenotyping of regulatory T cells after liver transplantation.
Gronert Álvarez A; Fytili P; Suneetha PV; Kraft AR; Brauner C; Schlue J; Krech T; Lehner F; Meyer-Heithuis C; Jaeckel E; Klempnauer J; Manns MP; Cornberg M; Wedemeyer H
Liver Transpl; 2015 Mar; 21(3):381-95. PubMed ID: 25451888
[TBL] [Abstract][Full Text] [Related]
25. IL-17A increases MHC class I expression and promotes T cell activation in papillary thyroid cancer patients with coexistent Hashimoto's thyroiditis.
Han LT; Hu JQ; Ma B; Wen D; Zhang TT; Lu ZW; Wei WJ; Wang YL; Wang Y; Liao T; Ji QH
Diagn Pathol; 2019 Jun; 14(1):52. PubMed ID: 31159823
[TBL] [Abstract][Full Text] [Related]
26. Programmed death-ligand 1 overexpression is a prognostic marker for aggressive papillary thyroid cancer and its variants.
Chowdhury S; Veyhl J; Jessa F; Polyakova O; Alenzi A; MacMillan C; Ralhan R; Walfish PG
Oncotarget; 2016 May; 7(22):32318-28. PubMed ID: 27086918
[TBL] [Abstract][Full Text] [Related]
27. Tumor Mutation Burden Predicts Relapse in Papillary Thyroid Carcinoma With Changes in Genes and Immune Microenvironment.
Guo M; Chen Z; Li Y; Li S; Shen F; Gan X; Feng J; Cai W; Liu Q; Xu B
Front Endocrinol (Lausanne); 2021; 12():674616. PubMed ID: 34248843
[TBL] [Abstract][Full Text] [Related]
28. Differences in Maturation Status and Immune Phenotypes of Circulating Helios
Zhang Y; Zhang J; Shi Y; Shen M; Lv H; Chen S; Feng Y; Chen H; Xu X; Yang T; Xu K
Front Immunol; 2021; 12():628504. PubMed ID: 34054801
[TBL] [Abstract][Full Text] [Related]
29. Characteristics and PD-1 expression of peripheral CD4+CD127loCD25hiFoxP3+ Treg cells in chronic HCV infected-patients.
Shen T; Zheng J; Liang H; Xu C; Chen X; Zhang T; Xu Q; Lu F
Virol J; 2011 Jun; 8():279. PubMed ID: 21645420
[TBL] [Abstract][Full Text] [Related]
30. [Analysis of frequency of peripheral blood CD4+; CD25(high);Tregs and CD4+; CD25(low);T cells and expression of PD-1 in SLE and RA patients].
Niu Q; Huang ZC; Cai B; Wang LL; Feng WH
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2011 Jan; 27(1):23-5. PubMed ID: 21208558
[TBL] [Abstract][Full Text] [Related]
31. Programmed Death-Ligand 1 Expression in Papillary Thyroid Cancer and Its Correlation with Clinicopathologic Factors and Recurrence.
Shi RL; Qu N; Luo TX; Xiang J; Liao T; Sun GH; Wang Y; Wang YL; Huang CP; Ji QH
Thyroid; 2017 Apr; 27(4):537-545. PubMed ID: 27825291
[TBL] [Abstract][Full Text] [Related]
32. Dynamics of regulatory T cells (T
Aggarwal S; Sharma SC; N Das S
J Surg Oncol; 2017 Dec; 116(8):1103-1113. PubMed ID: 28833201
[TBL] [Abstract][Full Text] [Related]
33. Association between PD-1/PD-L1 and T regulate cells in early recurrent miscarriage.
Li G; Lu C; Gao J; Wang X; Wu H; Lee C; Xing B; Zhang Q
Int J Clin Exp Pathol; 2015; 8(6):6512-8. PubMed ID: 26261529
[TBL] [Abstract][Full Text] [Related]
34. The success of assisted reproduction technologies in relation to composition of the total regulatory T cell (Treg) pool and different Treg subsets.
Schlossberger V; Schober L; Rehnitz J; Schaier M; Zeier M; Meuer S; Schmitt E; Toth B; Strowitzki T; Steinborn A
Hum Reprod; 2013 Nov; 28(11):3062-73. PubMed ID: 23925397
[TBL] [Abstract][Full Text] [Related]
35. Preferential accumulation of regulatory T cells with highly immunosuppressive characteristics in breast tumor microenvironment.
Syed Khaja AS; Toor SM; El Salhat H; Faour I; Ul Haq N; Ali BR; Elkord E
Oncotarget; 2017 May; 8(20):33159-33171. PubMed ID: 28388539
[TBL] [Abstract][Full Text] [Related]
36. Flow cytometry-based methods for studying signaling in human CD4+CD25+FOXP3+ T regulatory cells.
Crellin NK; Garcia RV; Levings MK
J Immunol Methods; 2007 Jul; 324(1-2):92-104. PubMed ID: 17582431
[TBL] [Abstract][Full Text] [Related]
37. Circulating Regulatory T Cell Subsets in Patients with Sarcoidosis.
Kudryavtsev I; Zinchenko Y; Starshinova A; Serebriakova M; Malkova A; Akisheva T; Kudlay D; Glushkova A; Yablonskiy P; Shoenfeld Y
Diagnostics (Basel); 2023 Apr; 13(8):. PubMed ID: 37189479
[TBL] [Abstract][Full Text] [Related]
38. Regulatory T cells and IL-17A levels in noninfectious uveitis.
Guedes MCE; Arroz MJ; Martins C; Angelo-Dias M; Proença RD; Borrego LM
Graefes Arch Clin Exp Ophthalmol; 2020 Jun; 258(6):1269-1278. PubMed ID: 32200408
[TBL] [Abstract][Full Text] [Related]
39. STRA6 regulates tumor immune microenvironment and is a prognostic marker in BRAF-mutant papillary thyroid carcinoma.
He W; Sun Y; Ge J; Wang X; Lin B; Yu S; Li Y; Hong S; Xiao H
Front Endocrinol (Lausanne); 2023; 14():1076640. PubMed ID: 36843593
[TBL] [Abstract][Full Text] [Related]
40. Remodeling of the tumor microenvironment via disrupting Blimp1
Dixon ML; Luo L; Ghosh S; Grimes JM; Leavenworth JD; Leavenworth JW
Mol Cancer; 2021 Nov; 20(1):150. PubMed ID: 34798898
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
